electroCore (NASDAQ:ECOR) Stock: Insider Thomas Errico Acquires 10,000 Shares

electroCore, Inc. (NASDAQ:ECOR – Get Free Report) Director Thomas Errico bought 10,000 shares of the stock in a transaction that occurred on Thursday, November 12th. The shares were bought at an average cost of $5.44 per share, with a total value of $54,400.00. Following the completion of the purchase, the director directly owned 373,904 shares in the company, valued at $2,034,037.76. This represents a 2.75% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

electroCore Stock Performance

Shares of ECOR opened at $5.25 on Monday. The stock has a 50-day simple moving average of $9.00 and a 200-day simple moving average of $7.74. The stock has a market capitalization of $48.46 million, a PE ratio of -3.78 and a beta of 1.23. electroCore, Inc. has a 1 year low of $4.37 and a 1 year high of $12.70.

electroCore (NASDAQ:ECOR – Get Free Report) last released its earnings results on Wednesday, November 4th. The company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.14. The firm had revenue of $9.69 million for the quarter, compared to analysts’ expectations of $10.93 million. Analysts predict that electroCore, Inc. will post -1.17 EPS for the current year.

Institutional Investors Weigh In On electroCore

An institutional investor recently bought a new stake in electroCore stock. Cetera Investment Advisers acquired a new stake in electroCore, Inc. (NASDAQ:ECOR – Free Report) during the third quarter, according to its most recent filing with the SEC. The firm acquired 32,950 shares of the company’s stock, valued at approximately $357,000. Cetera Investment Advisers owned about 0.36% of electroCore at the end of the most recent reporting period. Institutional investors own 26.74% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a research note on Monday, September 21st. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $18.00.

Get Our Latest Research Report on ECOR

About electroCore

(Get Free Report)

electroCore is a medical technology company that develops non-invasive bioelectronic therapies. Its products use non-invasive vagus nerve stimulation (nVNS), which delivers gentle electrical stimulation through the skin to activate the vagus nerve. The company’s gammaCore device is used for the treatment of certain headache conditions, including migraine and cluster headache, subject to its regulatory clearances and indications. electroCore also offers Truvaga, a consumer wellness product that uses non-invasive vagus nerve stimulation.

Read More

Insider Buying and Selling by Quarter for electroCore (NASDAQ:ECOR)

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.